Zymeworks Inc. ZYME
$22.56
▼ -0.37% 24H
About
Zymeworks Inc. is a biotechnology company that focuses on innovating biotherapeutics for the treatment of cancer and autoimmune diseases. The company's core mission revolves around developing novel, multifunctional therapeutics with the potential to improve efficacy and reduce side effects compared to conventional canc…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees243
TickerZYME
Statistics
Market Cap$1.66B
Revenue (TTM)$106.0M
Net Income-$81.1M
Net Margin-76.6%
EPS$-1.08
P/E3.79
P/S20.79
P/B6.38
EV/EBITDA-12.26
ROE-42.0%
Dividend Yield—
Price$22.56
Data: Twelve Data · Revenue = mcap / P/S